Class 4 Medicines Defect Notification: Moclobemide 150mg tablets (Lexon UK Ltd)
MHRA Class 4 Medicines Defect Notification: Moclobemide 150mg tablets (Lexon UK Ltd) Drug alert number: EL(25)A/50 Date issued: 25 November 2025 Lexon UK Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification is missing important updated safety information. DMRC reference number: DMRC – 37693641 [...]
The post Class 4 Medicines Defect Notification: Moclobemide 150mg tablets (Lexon UK Ltd) appeared first on Community Pharmacy England.
Recent Comments